Cigna Corp. (CI) Misses Q2 EPS Views; Updates FY16 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Leerink Partners Cuts Price Target on Cigna Corp. (CI) to $155 Following 2Q Miss
August 1, 2016 10:10 AM EDTLeerink Partners maintained an Outperform rating on CIGNA (NYSE: CI), and cut the price target to $155.00 (from $160.00), following the company's 2Q earnings report. The company reported an EPS miss of 39c and $1.20 guide-down driven mostly by Group Life & Disability but to a lesser extent Global Healthcare.
Analyst Ana Gupte commented, "We revise our CI 2017E and 2018E EPS to $9.50 & $10.88 after a surprise miss and guide-down on Disability & Life as well as a smaller miss in Healthcare. The miss in... More
